Literature DB >> 18413552

Length of hospital stay and postdischarge mortality in patients with pulmonary embolism: a statewide perspective.

Drahomir Aujesky1, Roslyn A Stone, Sunghee Kim, Elsa J Crick, Michael J Fine.   

Abstract

BACKGROUND: The optimal length of stay (LOS) for patients with pulmonary embolism (PE) is unknown. Although reducing LOS is likely to save costs, the effects on patient safety are unclear. We sought to identify patient and hospital factors associated with LOS and assess whether LOS was associated with postdischarge mortality.
METHODS: We evaluated patients discharged with a primary diagnosis of PE from 186 acute care hospitals in Pennsylvania (January 2000 through November 2002). We used discrete survival models to examine the association between (1) patient and hospital factors and the time to discharge and (2) LOS and postdischarge mortality within 30 days of presentation, adjusting for patient and hospital factors.
RESULTS: Among 15 531 patient discharges with PE, the median LOS was 6 days, and postdischarge mortality rate was 3.3%. In multivariate analysis, patients from Philadelphia were less likely to be discharged on a given day (odds ratio [OR], 0.82; 95% confidence interval [CI], 0.73-0.93), as were black patients (OR, 0.88; 95% CI, 0.82-0.94).The odds of discharge decreased notably with greater patient severity of illness and in patients without private health insurance. Adjusted postdischarge mortality was significantly higher for patients with an LOS of 4 days or less (OR, 1.55; 95% CI, 1.21-2.00) relative to those with an LOS of 5 to 6 days.
CONCLUSIONS: Several hospital and patient factors were independently associated with LOS. Patients with a very short LOS had greater postdischarge mortality relative to patients with a typical LOS, suggesting that physicians may inappropriately select patients with PE for early discharge who are at increased risk of complications.

Entities:  

Mesh:

Year:  2008        PMID: 18413552     DOI: 10.1001/archinte.168.7.706

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  14 in total

1.  The cost-effectiveness and cost-utility analysis of the use of enoxaparin compared with heparin for venous thromboembolism prophylaxis in medical inpatients in Iran.

Authors:  Mohammadreza Amirsadri; Sarah Mousavi; Ali Karimipour
Journal:  Daru       Date:  2019-07-31       Impact factor: 3.117

2.  Length of hospital stay is shorter in South Asian patients with acute pulmonary embolism.

Authors:  Stephanie F Smith; Nicholas D Gollop; Hardeep Uppal; Suresh Chandran; Rahul Potluri
Journal:  Heart Asia       Date:  2014-01-23

3.  Longer lengths of stay and higher risk of mortality among inpatients of physicians with more years in practice.

Authors:  William N Southern; Eran Y Bellin; Julia H Arnsten
Journal:  Am J Med       Date:  2011-07-23       Impact factor: 4.965

4.  Mortality at 30 and 90 days in elderly patients with pulmonary embolism: a retrospective cohort study.

Authors:  Hernan Polo Friz; Mauro Molteni; Davide Del Sorbo; Lorenzo Pasciuti; Matteo Crippa; Giulia Villa; Dario Francesco Meloni; Laura Primitz; Andrea Galli; Magda Rognoni; Luca Cavalieri d'Oro; Guido Arpaia; Claudio Cimminiello
Journal:  Intern Emerg Med       Date:  2014-12-25       Impact factor: 3.397

5.  Increased Risk of Mortality among Patients Cared for by Physicians with Short Length-of-Stay Tendencies.

Authors:  William N Southern; Julia H Arnsten
Journal:  J Gen Intern Med       Date:  2015-01-24       Impact factor: 5.128

6.  Predictors of early postdischarge mortality in critically ill patients: a retrospective cohort study from the California Intensive Care Outcomes project.

Authors:  Eduard E Vasilevskis; Michael W Kuzniewicz; Brian A Cason; Rondall K Lane; Mitzi L Dean; Ted Clay; Deborah J Rennie; R Adams Dudley
Journal:  J Crit Care       Date:  2010-08-16       Impact factor: 3.425

7.  National Trends in Pulmonary Embolism Hospitalization Rates and Outcomes for Adults Aged ≥65 Years in the United States (1999 to 2010).

Authors:  Karl E Minges; Behnood Bikdeli; Yun Wang; Nancy Kim; Jeptha P Curtis; Mayur M Desai; Harlan M Krumholz
Journal:  Am J Cardiol       Date:  2015-08-14       Impact factor: 2.778

8.  Outcomes considered most important by emergency physicians when determining disposition of patients with pulmonary embolism.

Authors:  Christopher Kabrhel; Weston Sacco; Shan Liu; Praveen Hariharan
Journal:  Int J Emerg Med       Date:  2010-10-19

9.  Timing of discharge follow-up for acute pulmonary embolism: retrospective cohort study.

Authors:  David R Vinson; Dustin W Ballard; Jie Huang; Adina S Rauchwerger; Mary E Reed; Dustin G Mark
Journal:  West J Emerg Med       Date:  2015-01-12

10.  Apixaban Reduces Hospitalizations in Patients With Venous Thromboembolism: An Analysis of the Apixaban for the Initial Management of Pulmonary Embolism and Deep-Vein Thrombosis as First-Line Therapy (AMPLIFY) Trial.

Authors:  Xianchen Liu; Margot Johnson; Jack Mardekian; Hemant Phatak; John Thompson; Alexander T Cohen
Journal:  J Am Heart Assoc       Date:  2015-12-01       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.